#42: Pharma’s First Trillionaire: Eli Lilly Breaks Healthcare History

• 🧬 U.S. Scientists have discovered Optimal Genome Mapping, a new genetic tool that reveals hidden chromosome flaws that may explain repeated miscarriages. (ETHealth)

• 🤖 AI vs Superbugs: UK and GSK team up in £45 million AI project to decode drug-resistant infections, speed up new antibiotics and predict future outbreaks. (BBC)

• 🦵🏻 Gout be kidding me, this pill saves hearts too! Study shows Colchicine, a med used for joint pain, cuts heart attack and stroke risk by calming artery inflammation. (MNT)

• 💥 Pfizer drops Rimegepant in India: a melt-in-the-mouth pill for migraines that delivers relief for 48 hours, with zero rebound headaches! (ETPharma)

• 🧠 India approves Eli Lilly’s Donanemab, the first disease-modifying Alzheimer’s drug that slows the disease progression in early-stage patients. (IndiaToday)

• 🫁 Bayer scores an FDA nod for its new pill-based lung-cancer treatment, tumors shrank in as many as 71% of cases in trials. (Reuters)

🇮🇳 India

• 🦠 WHO’d have thought? AIIMS Delhi joins the elite Unity Study network, one of the few WHO pandemic hubs worldwide. India now has a rapid-response hotspot to detect and fight outbreaks fast. (ETHealth)

• 💥 Cough syrup chaos alert! After a string of child deaths tied to toxic syrups, the Centre is now weighing a prescription‑only rule for all children’s cough medicines. (cnbctv18)

• 🛒 Add to cart? Nope! FSSAI just ordered the immediate removal of all misleading ORS sugary drinks from store shelves and e-commerce sites. (TheHindu)

• 🕵️ Health cover heist! India loses ₹8-10,000 Cr every year to fake claims, hiking premiums, and draining public funds. Experts call for AI checks and tighter oversight. (TOI)

🌏️ Global

• 😨 The U.S. took its wallet and left. Now the WHO’s cutting over 2,000 jobs by 2026 to patch a billion-dollar budget gap. (ETHealth)

• 🧬 Billionaires playing god? OpenAI and Coinbase execs are backing gene-edited embryo startups (banned in the U.S.) promising healthier, higher-IQ babies. Critics are screaming eugenics. (wsj)

• 🩺 From stethoscopes to suitcases! A record 4,880 overseas-trained doctors quit the UK in 2024. Reasons: hostility, burnout, poor support, and tough visa hurdles. (TheGuardian)

🇮🇳 India

• 💰 ₹1,000+ Cr pharma bet: A consortium led by WhiteOak Capital is investing in Ahmedabad-based La Renon Healthcare for its booming chronic meds pipeline. (VCCircle)

🌏️ Global

• 💵Eli Lilly is now the first $1T pharma company, proving weight-loss drugs aren’t just changing waistlines; they’re changing healthcare.  (Reuters)

• 💸 Slim-deal alert! In the U.S., Novo is cutting out-of-pocket expenditures for its weight-loss drugs from $499 to $349 a month. (CNN)

• ⌚ WHOOP,  a health wearable, is eyeing an IPO: riding a 75% surge in subscribers and an ambitious push into non-invasive glucose tracking (F/I)

• 💰 Mega diagnostics deal: Abbott is buying Exact Sciences, a U.S.-based biotech giant, in a $23B takeover to supercharge its cancer screening portfolio. (Reuters)

• 📈 GE Healthcare goes all-in! Drops a $2.3 B deal to buy Canada’s imaging software firm Intelerad, supercharging its cloud & AI imaging for hospitals and clinics. (HealthcareIT)

📢 Enjoyed this edition?  Forward it to a friend or colleague who’d love to stay informed! They can subscribe here.